Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Semaphorin 3F ELISA Kit (AC2939)
Cat.#: ASET-1528
Specifications
Description Human Semaphorin 3F ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Semaphorin 3F concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.05 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1836 Human MAdCAM1 ELISA Kit (AC3247) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry ASET-2312 Human Pannexin 1 ELISA Kit (AC3723) Quantitative inquiry ASET-2063 Mouse ABCG1 ELISA Kit (AC3474) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-1503 Mouse NMDAR2A ELISA Kit (AC2914) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-1291 Human beta Nerve Growth Factor ELISA Kit (AC2702) Quantitative inquiry ASET-1547 Mouse Synaptophysin ELISA Kit (AC2958) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket